spot_img
Wednesday, November 18, 2026

Made Scientific to expand Princeton campus under long-term cell therapy manufacturing deal with Orca Bio

Cell therapy contract development and manufacturing organization (CDMO) Made Scientific has entered into a long-term commercial manufacturing partnership with Orca Bio to produce TREGZI, an FDA-approved cell therapy for adults with blood cancers, at Made Scientific’s Princeton campus.

To support the agreement and accommodate broader commercial demand, Made Scientific plans to add a 45,000-square-foot facility adjacent to its existing Princeton site. Once completed, the expansion will establish an integrated Princeton manufacturing campus and bring Made Scientific’s total operational footprint across New Jersey and East Norriton, Pennsylvania, to approximately 200,000 square feet.

The planned New Jersey expansion will house commercial-scale manufacturing suites, quality control laboratories, warehousing, and cryogenic storage. Made Scientific is currently advancing toward U.S. Food and Drug Administration (FDA) licensure of its Princeton facilities to support Orca Bio’s commercial supply chain.

“Commercial supply is a decades-long commitment to patients, and it starts with capacity that is ready when a therapy is,” Syed Husain, chairman and CEO of Made Scientific, said. “Orca Bio is building its East Coast manufacturing network with us, and our expansion on the Princeton campus gives us room to grow with them as TREGZI reaches more patients.”

TREGZI is a precision-engineered allogeneic cell therapy created from matched donor cells for adult patients undergoing transplant treatment for hematological malignancies.

For California-based Orca Bio, establishing dedicated production in Mercer County creates a bicoastal manufacturing network alongside its primary commercial facility in Sacramento. According to the companies, operating out of Princeton will shorten delivery timelines for East Coast patients while allowing Orca Bio to manufacture therapies using European donor cells—expanding international donor sourcing flexibility.

“Because TREGZI is made for each patient from matched donor cells, reliable supply depends on where and how we manufacture,” Jeroen Bekaert, Ph.D., co-founder and president of Orca Bio, said. “The site in Princeton gives Orca Bio a dedicated East Coast home that complements our Sacramento operations and opens further access to domestic and international donors. With Made Scientific supporting both our clinical and commercial manufacturing, we’re well positioned to expand access for patients.”

Backed by long-term strategic owner GC Corporation, Made Scientific specializes in clinical- and commercial-stage development, manufacturing, and release of autologous and allogeneic cell therapies.

+ posts

Get the Latest News

Sign up to get all the latest news, offers and special announcements.

Get our Print Edition

All the latest updates, delivered.

Latest Posts

Get the Latest News

Sign up to get all the latest news, offers and special announcements.

Get our Print Edition

All the latest updates, delivered.